Advertisement
News
Advertisement

NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011

Wed, 01/12/2011 - 7:37am
Bio-Medicine.Org

NEW YORK, Jan. 12, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that Dr. Robin Smith, the Company's Chairman and CEO, will present on Wednesday, January 12, 2011 at the OneMedForum 2011 at 9:15 AM PST and at the Biotech Showcase™ 2011 at 11:00 AM PST. Both events will be held in San Francisco, California.

The OneMedForum 2011 will be held at the Sir Francis Drake Hotel at 450 Powell Street, San Francisco, CA and Dr. Robin Smith will present in the Renaissance Room. The Biotech Showcase™ 2011 will be held at Parc 55 Wyndham San Francisco, CA and Dr. Robin Smith will present in the Stockton Room.

In recapping highlights of 2010, the Company will review its multiple accomplishments for the year.   In November 2010, we raised $19 million from two concurrent offerings. These funds will help us to grow our revenue lines of businesses in the US and China, including the closing of our acquisition of Progenitor Cell Therapy LLC, and further assist in our growth.  NeoStem was also named "Best Stem Cell Company, 2010" in The New Economy's Biotech Awards.  Additionally, The Vatican's Pontifical Council has undertaken to commit $1 million to joint ventures with NeoStem and the Stem for Life Foundation, a not-for-profit entity NeoStem participated in founding, to expand research and raise awareness of adult stem cell therapies.We also began generating revenues from what we believe will be just the beginning of a pipeline of stem cell-based regenerative medicine therapies, a key element of our growth strategy in both the United States and China, with our collaboration with Wendeng Hospital in China whereby patients are being offered the benefit of the latest technology from the US in the treatment of a range of

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading